右美托咪定在老年患者无痛胃肠镜检查中的应用

doi:10.20047/j.issn1673-7210.2023.07.26

Abstract
Figure/Table
References (29)
Related Citation (15)

Download: PDF (554 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application effect of Dexmedetomidine in painless gastroenteroscopy in elderly patients. Methods A total of 340 patients who underwent painless gastroenteroscopy in Fuxin General Hospital of Liaoning Health Industry Group from September 2018 to April 2019 were selected as the research objects, and they were divided into two groups according to random number table method, with 170 patients in each group. The control group was treated with 1.0 mg/kg Propofol intravenously + 0.1 μg/kg Fentanyl, and maintained with 2 mg/(kg·h) Propofol pump during gastroenteroscopy; observation group was additionally injected with Dexmedetomidine for 15 min at 30 μg. The induced dosage of Propofol and recovery time were compared between two groups; the heart rate (HR), mean arterial pressure (MAP), and oxygen saturation (SO2) of two groups were compared before administration (T0), before induction (T1), at the beginning of examination (T2), 10 min after examination (T3), and after examination when Stward score reached 6 points (T4); the incidence of hiccup, bradycardia, tachycardia, intraoperative hypotension, and respiratory depression of two groups were compared. Results At T2-T3, HR, MAP, and SO2 in control group were lower than those at T0, and the differences were statistically significant (P＜0.05); at T1-T4, HR, MAP, and SO2 in observation group were higher than those in control group, and the differences were statistically significant (P＜0.05). The induced dosage of Propofol in observation group was lower than that in control group, and the recovery time was shorter than that in control group, and the differences were statistically significant (P＜0.05). The incidence of hiccup, bradycardia, tachycardia, intraoperative hypotension, and respiratory depression in observation group was lower than that in control group, and the difference was statistically significant (P＜0.05). Conclusion Dexmedetomidine in painless gastroenteroscopy patients can reduce the amount of Propofol induction, shorten the recovery time, reduce the impact on hemodynamics, and reduce the incidence of adverse reactions.

Key words： Dexmedetomidine Painless gastroenteroscopy Heart rate Mean artery pressure Oxygen saturation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	BAO YU1 SHANG YU2

Cite this article:

BAO YU1 SHANG YU2. Application of Dexmedetomidine in painless gastroenteroscopy in elderly patients[J]. 中国医药导报, 2023, 20(7): 119-122.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.07.26 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I7/119

[1] 刘玲丽，何靖.门诊无痛肠镜的研究进展[J].河北医药，2020，42（10）：127-132.
[2] 余婉秋，李禹琼，朱圣姬，等.苯磺酸瑞马唑仑与丙泊酚用于无痛结肠镜检查的有效性及安全性的随机、单盲、平行对照研究[J].贵州医药，2020，44（6）：846-849.
[3] 中华医学会麻醉学分会，中华医学会消化内镜学分会.中国消化内镜诊疗镇静/麻醉的专家共识[J].临床麻醉学杂志，2014，30（9）：920-927.
[4] Chen SH，Yuan TM，Zhang J，et al. Remimazolam tosilate in upper gastrointestinal endoscopy：A multi center，randomized，non-inferiority，phase Ⅲ trial [J]. J Gastroenterol Hepatol，2020，36（2）：471-481.
[5] 朱艺霞，王明虹，徐曈.舒芬太尼、依托咪酯对骨科高龄患者术中应激反应与认知功能的影响[J].中国医药科学，2022，12（1）：144-148.
[6] Zhu Y，Yang S，Zhang R，et al. Using clinical-based discharge criteria to discharge patients after ophthalmic ambulatory surgery under general anesthesia：An observational study [J]. J Perianesth Nurs，2020，35（6）：586-591.
[7] 拾翠翠，孙剑，张玉凤.瑞马唑仑在儿童无痛胃镜检查中的应用[J].临床与病理杂志，2021，41（12）：2918-2922.
[8] 涂远艳，李璟，张勇.舒芬太尼复合丙泊酚静脉全麻在小儿胃肠镜检查中的应用[J].白求恩医学杂志，2017，15（2）：188-190.
[9] 任大鹏，张春燕，蒋亚明，等.不同剂量右美托咪啶对甲状腺手术患者全身麻醉拔管期心血管系统、苏醒时间的影响评价[J].中国全科医学，2020，23（S1）：113-115.
[10] 杨鹤，刘缚鲲，郑莉，等.纳布啡和舒芬太尼分别复合丙泊酚用于门诊无痛胃肠镜检查的临床观察[J].临床和实验医学杂志，2018，17（12）：1340-1343.
[11] The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels [M]. 9th ed. Boston，Mass：Little，Brown & Co，1994：253-256.
[12] Nasreddine ZS，Phillips NA，Bedirian V，et al. The montreal cognitive assessment，MoCA：a brief screening tool for mild cognitive impairment [J]. J Am Geriatr Soc，2005，53（4）：695-699.
[13] 武晓丽，李其昂，李悦.胃肠镜诊疗中镇静/麻醉新进展[J].国际麻醉学与复苏杂志，2020（1）：71-75.
[14] 李思彤，张毅，叶刚，等.甲苯磺酸瑞马唑仑联合舒芬太尼在老年患者无痛结直肠镜镇静中的有效性和安全性[J].武汉大学学报（医学版），2022，43（3）：480-484.
[15] 陈洁娟，邹小华，陈佳，等.不同剂量阿芬太尼复合丙泊酚用于无痛胃镜检查的效果[J].临床麻醉学杂志，2022， 38（1）：46-51.
[16] 段怡，张欢，高翠荣，等.意识指数监测下瑞芬太尼或舒芬太尼复合丙泊酚在妇科短小手术中的比较[J].临床麻醉学杂志，2019，35（12）：1189-1192.
[17] 康鑫鑫，王中玉，周俊飞，等.苯磺酸瑞马唑仑联合阿芬太尼在肥胖患者无痛胃镜检查麻醉中的应用[J].中华实用诊断与治疗杂志，2022，36（7）：744-746.
[18] 王金伙，郭建荣.阿芬太尼的临床药理特性及其麻醉应用进展[J].中国临床药理学与治疗学，2021，26（7）：824- 829.
[19] 管忍，董希玮，马宁，等.基于计算机模拟概述创新性软药瑞马唑仑[J].国际麻醉学与复苏杂志，2020，41（10）：946-954.
[20] 陈瑾，马红，刘美玉.瑞马唑仑复合瑞芬太尼用于无痛胃镜检查的半数有效剂量[J].临床麻醉学杂志，2021， 37（9）：953-956.
[21] 杨光，高逸龙，田慧，等.右美托咪定对椎管内麻醉手术患者应激反应的影响[J].河北医药，2021，43（11）：1693- 1695.
[22] 李子玮，郝守则.右美托咪定联合舒芬太尼对老年无痛胃镜检查患者依托咪酯所致肌颤的影响[J].老年医学研究，2022，3（2）：14-17.
[23] 郑景丹，郑荣珍.不同给药方法阿芬太尼与舒芬太尼在120例全身麻醉诱导时诱发咳嗽情况观察[J].延边大学医学学报，2020，43（3）：203-204.
[24] 钱欣欣，钱洁玉，董素玲.无痛肠镜在临床中的应用价值及肠镜检查患者生理应激的影响[J].医学理论与实践，2021，34（1）：121-123.
[25] 王贝贝，王品，王侠，等.阿芬太尼联合丙泊酚用于老年患者无痛胃肠镜检查的效果[J].国江苏医药，2022，48（7）：715-718.
[26] 龚晓毅，翁立阳，郭冬冬，等.小剂量艾司氯胺酮对无痛胃肠镜检查时丙泊酚联合瑞芬太尼麻醉效果的影响[J].中国临床研究，2022，35（1）：61-65.
[27] 殷霞丽，倪杰.依托咪酯联合瑞芬太尼在无痛电子纤维支气管镜检查中的应用[J].中国临床研究，2020，33（11）：1520-1522，1526．
[28] 赵静.右美托咪定复合依托咪酯在老年无痛胃肠镜中的应用效果及对应激反应的影响[J].中国当代医药，2021， 28（5）：175-178.
[29] 陈绪军.依托咪酯与丙泊酚配伍麻醉对无痛胃肠镜检查安全性及患者认知功能的影响[J].中外医学研究，2021， 19（35）：70-73.